North Carolina 2025 Session Status: Passed House Bipartisan · 30 R · 3 D cosponsors

HB 163 — Pharmacy Benefits Manager Provisions.

Last action — Regular Message Sent To Senate

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the House. Introduced February 21, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Senate.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 74% · high confidence

  • Passed House

    Current position in the legislative process.

  • 35 sponsors

    3 primary, 32 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (30 R · 3 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

369 added · 432 removed

Plain-language change summary

The amendments to Bill HB 163 added a definition for "national average drug acquisition cost" and clarified the meaning of "specialty drug" as well as "specialty pharmacy accreditation." It also removed the previous definition of "generic equivalent." These changes are important because they aim to improve transparency around drug pricing and classifications, which can help consumers and healthcare providers make better-informed decisions about prescription medications.

→
Previous
Latest
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 H 2 HOUSE BILL 163 Committee Substitute Favorable 4/1/25 Short Title:
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 H 1 HOUSE BILL 163 Short Title:
Representatives Rhyne, Blackwell, Huneycutt, and Lowery (Primary Sponsors).
For a complete list of sponsors, refer to the North Carolina General Assembly web site.
February 24, 2025 A BILL TO BE ENTITLED AN ACT TO REGULATE THE USE OF SPREAD PRICING AND CONCESSIONS BY PHARMACY BENEFITS MANAGERS,TOESTABLISH UNIFORM STANDARDS FOR THETREATMENTOF SPECIALTYPHARMACYACCREDITATION BYPHARMACY BENEFITS MANAGERS, TO CLARIFY THE RIGHT TO A PHARMACY OF CHOICE, AND TO STRENGTHEN THE PROTECTIONS PROVIDED TO PHARMACIES DURING AUDITS.
Health, if favorable, Regulatory Reform, if favorable, Rules, Calendar, and Operations of the House February 24, 2025 A BILL TO BE ENTITLED AN ACT TO REGULATE THE USE OF SPREAD PRICING AND CONCESSIONS BY PHARMACY BENEFITS MANAGERS,TOESTABLISH UNIFORM STANDARDS FOR THETREATMENTOF SPECIALTYPHARMACYACCREDITATION BYPHARMACY BENEFITS MANAGERS, TO CLARIFY THE RIGHT TO A PHARMACY OF CHOICE, AND TO STRENGTHEN THE PROTECTIONS PROVIDED TO PHARMACIES DURING AUDITS.
(4c) Generic equivalent.
– A drug that meets all of the following criteria:
a.
Has an identical amount of the same active ingredients in the same dosage form as a non-generic drug.
b.
Meets applicable standards of strength, quality, and purity according to the United States Pharmacopeia or other nationally recognized compendium.
*H163-v-2* General Assembly Of North Carolina Session 2025 c.
If administered in the same amount as a non-generic drug, provides comparable therapeutic effects.
This term does not include a drug that is listed by the United States Food and Drug Administration as having unresolved bioequivalence concerns according to the Administration's most recent publication of approved drug products with therapeutic equivalence evaluations.
… (5a) High-deductible health plan.
– As defined under the Internal Revenue Code.
– The publicly available, most current pharmacy acquisition cost benchmark published by the Centers for Medicare and Medicaid Services (CMS), which reflects the average price that retail community pharmacies pay to acquire prescription drugs from wholesalers, excluding rebates and discounts.
– The approximate invoice price pharmacies pay for prescription medications in the United States calculated by the federal Centers for Medicare and Medicaid Services and published *H163-v-1* General Assembly Of North Carolina Session 2025 monthly on its website.
… (16a) Section 223.
If the national average drug acquisition cost is not available at the time a drug is administered or dispensed, then the national drug acquisition cost is the wholesale acquisition cost of the drug, as defined in Subchapter XIX, Chapter 7 of Title 42 of the United States Code.
– Section 223 of the Internal Revenue Code or its equivalent.
… (16a) Reserved for future codification purposes.
(16c) Specialtypharmacyaccreditation.–Acertificationgrantedbyanindependent, nationally recognized accrediting organization that evaluates a pharmacy's compliance with quality, safety, and service standards for handling, dispensing, and managing specialty medications.
(16c) Specialty pharmacy accreditation.
The accreditation may be issued by the Utilization Review Accreditation Commission (URAC), Accreditation Commission for Health Care (ACHC), the Joint Commission, their successors, or any similar nationally recognized accrediting organization.
– Affirmation that a pharmacist or pharmacyis capable of meetingthe requirements applicable to specialtydrugs provided by any of the following independent bodies:
a.
The Utilization Review Accreditation Commission.
b.
Accreditation Commission for Health Care, Inc.
c.
The Joint Commission.
58-56A-3 is amended by adding a new subsection to read:
"(c3) When calculating an insured's out-of-pocket cost for a covered prescription drug, a pharmacy benefits manager shall base the calculation on the net price of the prescription drug after taking into account all concessions associated with that prescription drug that the pharmacy benefits manager has received or will receive.
The current retail price shall not be used when calculating an insured's out-of-pocket cost for a prescription drug if the pharmacy benefits manager has received, is receiving, or will receive anyconcessions associatedwith thatparticular prescription drug." SECTION 1.2.(c) G.S.
(1) Reimburse a pharmacyor pharmacist for a prescription drugin an amount less than the national average drug acquisition cost for the prescription drug or pharmacy service at the time the drug is administered or dispensed, plus a professional dispensing fee.
(1) Reimburse a pharmacy or pharmacist for a prescription drug or pharmacy service in an amount less than the national average drug acquisition cost for the prescription drug or pharmacy service at the time the drug is administered or dispensed, plus a professional dispensing fee.
Page 2 House Bill 163-Second Edition General Assembly Of North Carolina Session 2025 (2) Reimburse a pharmacy or pharmacist for a prescription drug or pharmacy service in an amount less than the amount the pharmacy benefits manager reimburses itself or an affiliate for the same prescription drug or pharmacy.
(2) Reimburse a pharmacy or pharmacist for a prescription drug or pharmacy service in an amount less than the amount the pharmacy benefits manager reimburses itself or an affiliate for the same prescription drug or pharmacy.
(3) Base pharmacy reimbursement for prescription drugs on patient outcomes, scores, or metrics.
(3) Base pharmacy reimbursement on patient outcomes, scores, or metrics.
(4) Impose a point-of-sale or retroactive fee on a pharmacist, pharmacy, or insured.
Page 2 House Bill 163-First Edition General Assembly Of North Carolina Session 2025 (4) Impose a point-of-sale or retroactive fee on a pharmacist, pharmacy, or insured.
(7) Directly or indirectly divert, transfer, or otherwise redirect any prescription drug claims submitted by a pharmacy or pharmacist to any third-party discount card program, cash discount program, or any other non-insurance adjudication platform.
(8) Usepharmacybenefitsmanagerpolicydocumentswhichareincorporatedinto a pharmacy agreement, including, but not limited to, provider manuals, administrative guidelines, operational policies, ancillary documents, claims processing rules, and/or audit and compliance procedures, to materially change, alter, or modify the pharmacy agreement, to modify, limit, or negate reimbursement rates, payment terms, or other financial obligations, or introduce material changes to the definitions of brand and generic drugs, claims adjudication, audit process, or contractual rights of the pharmacy or pharmacist.
… (g) A pharmacy benefits manager may not prohibit a pharmacy or pharmacist that dispenses a pharmaceutical product from, nor may a pharmacy benefits manager penalize the pharmacy or pharmacist for, informing an individual about the cost of the pharmaceutical product, the amount in reimbursement that the pharmacy or pharmacist receives for dispensing the pharmaceutical product, the cost and clinical efficacy of a less expensive alternative to the pharmaceutical product, or any difference between the cost to the individual under the individual's pharmacy benefits plan or program and the cost to the individual if the individual purchases the pharmaceutical product without making a claim for benefits under the individual's pharmacy benefits plan or program." SECTION 1.2.(c) G.S.
…." SECTION 1.2.(d) G.S.
House Bill 163-Second Edition Page 3 General Assembly Of North Carolina Session 2025 (a) A pharmacy benefits manager shall not deny the right to of any properly licensed pharmacist or pharmacy to participate in a retail pharmacy network on the same terms and conditions of other similarly situated participants in the network.
(a) A pharmacy benefits manager shall not deny the right to of any properly licensed pharmacist or pharmacy to participate in a retail pharmacy network on the same terms and conditions of other similarly situated participants in the network.
… (d) A pharmacybenefits manager shall not charge a pharmacist or pharmacya fee related to participation in a retail pharmacy network." SECTION 1.3.
… (d) A pharmacybenefits manager shall not charge a pharmacist or pharmacya fee related to participation in a retail pharmacy network." SECTION 1.2.(e) G.S.
58-56A-25 is amended by adding a new subsection to read:
"(d) The provisions of Article 4C of Chapter 90 of the General Statutes apply to an audit of a pharmacy or pharmacist conducted by a pharmacy benefits manager, insurer, or third-party administrator and are enforceable by the Commissioner." SECTION 1.3.
Show all 116 changed rows (76 more)
Previous
Latest
(a) Effective May 1, 2026, and quarterly thereafter, every pharmacy benefits manager licensed in this State shall file a report with the Commissioner that contains all of the following information for the applicable time period:
(a) Effective April 1, 2026, and quarterly thereafter, every pharmacy benefits manager licensed in this State shall file a report with the Commissioner that contains all of the following information for the applicable time period:
(2) The aggregate amount of the concessions that the pharmacy benefits manager received from all drug manufacturers or wholesale distributors for each insurer contracting with the pharmacy benefits manager, detailed by each health benefit plan offered by the insurer.
House Bill 163-First Edition Page 3 General Assembly Of North Carolina Session 2025 (2) The aggregate amount of the concessions that the pharmacy benefits manager received from all drug manufacturers or wholesale distributors for each insurer contracting with the pharmacy benefits manager, detailed by each health benefit plan offered by the insurer.
Page 4 House Bill 163-Second Edition General Assembly Of North Carolina Session 2025 PART II.
PART II.
(2) "Contract provider" means a Contract provider.
Page 4 House Bill 163-First Edition General Assembly Of North Carolina Session 2025 (2) "Contract provider" means a Contract provider.
If the pharmacy is offered the opportunity to participate, participate as a contract provider, it House Bill 163-Second Edition Page 5 General Assembly Of North Carolina Session 2025 must participate or no provisions of G.S.
If the pharmacy is offered the opportunity to participate, participate as a contract provider, it must participate or no provisions of G.S.
(7) Impose upon an insured any copayment, amount of reimbursement, number of days of a drug supply for which reimbursement will be allowed, or any other payment or condition relating to the purchase of pharmacy services or products, including prescription drugs, from anypharmacy that is more costly or more restrictive than that which would be imposed upon the insured if the same services or products were purchased from either a mail-order pharmacy or any other pharmacy that is willing to provide the same services or products for the same cost and copayment as any mail-order service.
(7) Impose upon an insured any copayment, amount of reimbursement, number of days of a drug supply for which reimbursement will be allowed, or any other payment or condition relating to the purchase of pharmacy services or products, including prescription drugs, from anypharmacy that is more costly House Bill 163-First Edition Page 5 General Assembly Of North Carolina Session 2025 or more restrictive than that which would be imposed upon the insured if the same services or products were purchased from either a mail-order pharmacy or any other pharmacy that is willing to provide the same services or products for the same cost and copayment as any mail-order service.
Additionally, participating pharmacies shall be entitled to announce their Page 6 House Bill 163-Second Edition General Assembly Of North Carolina Session 2025 participation to their customers through a means acceptable to the pharmacy and the entity providing the health benefit plans.
Additionally, participating pharmacies shall be entitled to announce their participation to their customers through a means acceptable to the pharmacy and the entity providing the health benefit plans.
(i) ApprovalbyCommissioner.–TheCommissionershallnotapproveanyhealthbenefit plan providing pharmaceutical services which that does not conform to this section.
Page 6 House Bill 163-First Edition General Assembly Of North Carolina Session 2025 (i) ApprovalbyCommissioner.–TheCommissionershallnotapproveanyhealthbenefit plan providing pharmaceutical services which that does not conform to this section.
108A-68.2 is not a violation of this section." SECTION 2.2.
108A-68.2 is not a violation of this section." SECTION2.2.(a) Subsection(c2)of G.S.
G.S.
58-56A-3is recodified as subdivision (4c) of G.S.
58-56A-3 reads as rewritten:
58-56A-1.
"§ 58-56A-3.
SECTION 2.2.(b) G.S.
Consumer protections.
58-56A-1, as amended by Part I of this act and subsection (a) of this section, reads as rewritten:
… (b1) A pharmacy benefits manager shall not prohibit a pharmacist or pharmacy from chargingaminimalshippingandhandlingfeetotheinsuredforamailedordeliveredprescription if the pharmacist or pharmacy discloses all of the following to the insured before delivery:
"§ 58-56A-1.
(1) The fee will be charged.
Definitions.
(2) Thefeemaynotbereimbursedbythehealthbenefitplan,insurer,orpharmacy benefits manager.
The following definitions apply in this Article:
(3) The charge is specifically agreed to by the health benefit plan or pharmacy benefits manager.
… (4c) For purposes of this section, the term "generic equivalent" means a Generic equivalent.
(c) A pharmacy benefits manager shall not charge, or attempt to collect from, an insured a copayment that exceeds the total submitted charges by the network pharmacy.
– A drug that has meets all of the following criteria:
(c1) When calculating an insured's contribution to any out-of-pocket maximum, deductible, copayment, coinsurance, or other applicable cost-sharing requirement, the insurer or pharmacy benefits manager shall include any amounts paid by the insured, or on the insured's behalf, for a prescription that is either:either of the following:
a.
Has an identical amount of the same active ingredients in the same dosage form;
meets form as a non-generic drug.
b.
Meets applicable standards of strength, quality, and purity according to the United States Pharmacopeia or other nationally recognized compendium;
and which, if compendium.
c.
If administered in the same amount, would provide amount as a non-generic drug, provides comparable therapeutic effects.
The This term "generic equivalent" does not include a drug that is listed by the United States Food and Drug Administration as having unresolved bioequivalence concerns according to the Administration's most recent publication of approved drug products with therapeutic equivalence evaluations.
… (5a) High-deductible health plan.
– As defined under the Internal Revenue Code.
… (16a) Section 223.
– Section 223 of the Internal Revenue Code or its equivalent.
…." SECTION 2.2.(c) G.S.
58-56A-3(c1) reads as rewritten:
"(c1) When calculating an insured's contribution to any out-of-pocket maximum, deductible, copayment, coinsurance, or other applicable cost-sharing requirement, the insurer or pharmacy benefits manager shall include any amounts paid by the insured, or on the insured's behalf, for a prescription that is either:either of the following:
House Bill 163-Second Edition Page 7 General Assembly Of North Carolina Session 2025 (2) With an AB-rated generic equivalent if the insured has obtained authorization for the drug through any of the following:
(2) With an AB-rated generic equivalent if the insured has obtained authorization for the drug through any of the following:
This subsection shall not applyto an insured covered bya high deductible health plan, as that term is defined in section 223 of the Internal Revenue Code, plan, if its application would render the insured ineligible for a health savings account under section 223 unless (i) the insured has satisfied theminimum deductibleundersection223or(ii)the prescription qualifies as preventive care under section 223.
This subsection shall not applyto an insured covered bya high deductible health plan, as that term is defined in section 223 of the Internal Revenue Code, plan if its application would render the insured ineligible for a health savings account under section 223 unless (i) the insured has House Bill 163-First Edition Page 7 General Assembly Of North Carolina Session 2025 satisfied theminimum deductibleundersection223or(ii)the prescription qualifies as preventive care under section 223." SECTION 2.2.(d) G.S.
(c2) For purposes of this section, the term "generic equivalent" means a drug that has an identical amount of the same active ingredients in the same dosage form;
58-56A-3 is amended by adding a new subsection to read:
meets applicable standards of strength, quality, and purity according to the United States Pharmacopeia or other nationally recognized compendium;
"(f) A pharmacy benefits manager shall not prohibit an insured's selection of a pharmacy or pharmacist with respect to any pharmacy or pharmacist that has agreed to participate as a provider in a health benefit plan's network according to the terms offered by the insurer." SECTION 2.3.
and which, if administered in the same amount, would provide comparable therapeutic effects.
The term "generic equivalent" does not include a drug that is listed by the United States Food and Drug Administration as having unresolved bioequivalence concerns according to the Administration's most recent publication of approved drug products with therapeutic equivalence evaluations.
(c3) When calculating an insured's out-of-pocket cost for a covered prescription drug, a pharmacy benefits manager shall base the calculation on the net price of the prescription drug after taking into account all concessions associated with that prescription drug that the pharmacy benefits manager has received or will receive.
The current retail price shall not be used when calculating an insured's out-of-pocket cost for a prescription drug if the pharmacy benefits manager has received, is receiving, or will receive anyconcessions associatedwith thatparticular prescription drug.
(d) Any contract for the provision of a network to deliver health care services between a pharmacy benefits manager and insurer shall be made available for review by the Department.
(e) Repealed by Session Laws 2021-161, s.
1(b), effective October 1, 2021, and applicable to any contracts entered into, renewed, or amended on or after that date.
(f) A pharmacy benefits manager shall not prohibit an insured's selection of a pharmacy or pharmacist with respect to any pharmacy or pharmacist that has agreed to participate as a provider in a health benefit plan's network according to the terms offered by the insurer." SECTION 2.3.
… Page 8 House Bill 163-Second Edition General Assembly Of North Carolina Session 2025 (8) If an audit is conducted for a reason other than described in subdivision (6) of this subsection, the audit is limited to 100 selected prescriptions.Unless the audit is for reasons described in subdivision (6) of this subsection, the following audit restrictions shall apply to audits conducted by a pharmacy benefits manager:
… (8) If an audit is conducted for a reason other than described in subdivision (6) of this subsection, the audit is limited to 100 selected prescriptions.25 total prescriptions, including refills.
a.
A retail pharmacy may only be audited once per calendar quarter.
b.
The audit is restricted to the lesser of (i) one-tenth of one percent (0.1%) of the number of total prescription fills processed through the pharmacy benefits manager for that retail pharmacy in a calendar year or (ii) 50 prescription fills processed through the pharmacy benefits manager for that pharmacy in a calendar year.
… (a1) Prior to any recoupment, the entity conducting the audit shall provide the pharmacy with a summary describing the total recoupment amount and the approximate date, within a seven-day window, on which the recoupment will be assessed.
… (a1) Prior to any recoupment, the entity conducting the audit shall provide the pharmacy with a summary describing the total recoupment amount and the date on which the recoupment will be assessed.
G.S.
58-56A-25 is amended by adding a new subsection to read:
"(d) The provisions of Article 4C of Chapter 90 of the General Statutes apply to an audit of a pharmacy or pharmacist conducted by a pharmacy benefits manager, insurer, or third-party administrator and are enforceable by the Commissioner." SECTION 3.5.
CLARIFYING "HEALTH BENEFIT PLAN" DOES NOT INCLUDE LOCAL GOVERNMENT PLANS SECTION 4.
RULEMAKING AUTHORITY AND EFFECTIVE DATE Page 8 House Bill 163-First Edition General Assembly Of North Carolina Session 2025 SECTION 4.1.(a) The Commissioner may adopt temporary rules to implement Part I and Part II of this act.
G.S.
SECTION 4.1.(b) The North Carolina Board of Pharmacy may adopt temporary rules to implement Part III of this act.
58-3-167 reads as rewritten:
SECTION 4.2.
"§ 58-3-167.
Applicability of acts of the General Assembly to health benefit plans.
(a) As used in this section:
(1) "Health benefit plan" means an accident and health insurance policy or certificate;
a nonprofit hospital or medical service corporation contract;
a health maintenance organization subscriber contract;
a plan provided by a multiple employer welfare arrangement;
or a plan provided by another benefit arrangement, to the extent permitted by the Employee Retirement Income Security Act of 1974, as amended, or by any waiver of or other exception to that act provided under federal law or regulation.
"Health benefit plan" does House Bill 163-Second Edition Page 9 General Assembly Of North Carolina Session 2025 not mean any plan implemented or administered by the North Carolina or United States Department of Health and Human Services, or any successor agency, or its representatives.
"Health benefit plan" does not mean any plan implemented or administered by the State Health Plan for Teachers and State Employees.
"Health benefit plan" does not mean any plan consisting of one or more of any combination of benefits described in G.S.
58-68-25(b).
"Health benefit plan" does not mean any self-funded plan implemented or administered by a local government.
…." PART V.
RULEMAKING AUTHORITY AND EFFECTIVE DATE SECTION 5.1.(a) The Commissioner may adopt temporary rules to implement Part I and Part II of this act.
SECTION 5.1.(b) The North Carolina Board of Pharmacy may adopt temporary rules to implement Part III of this act.
SECTION 5.2.
Page 10 House Bill 163-Second Edition
House Bill 163-First Edition Page 9
⬇ Download PDF
View plain text versions (4)

Action History

  1. Regular Message Sent To Senate

  2. Regular Message Received From House

  3. Passed 1st Reading

  4. Ref To Com On Rules and Operations of the Senate

  5. Passed 2nd Reading

  6. Passed 3rd Reading

  7. Reptd Fav Com Sub 2

  8. Re-ref Com On Rules, Calendar, and Operations of the House

  9. Reptd Fav

  10. Cal Pursuant Rule 36(b)

  11. Placed On Cal For 04/29/2025

  12. Reptd Fav Com Substitute

  13. Re-ref Com On Regulatory Reform

  14. Passed 1st Reading

  15. Ref to the Com on Health, if favorable, Regulatory Reform, if favorable, Rules, Calendar, and Operations of the House

  16. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 32 co-sponsors · 144 not signed on · 9 voted No

Sponsors (3)

Co-sponsors (32)

Not signed on (144)

144 members have not signed on to this bill.

Show all 144 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Second Reading

Passed 106 Yea · 9 Nay · 5 Other
Party YeaNayPresentNot Voting
Democratic 32903
U 2000
Unaffiliated 6000
Republican 66002
Total 106905
% of votes cast 88%8%0%4%
How each member voted (120)
Member Party Vote
CharlesSmith — Yea
vonHaefen — Yea
Campbell — Yea
Reeder — Yea
C. Smith — Yea
F. Jackson — Yea
Abe Jones Democratic Yea
Aisha O. Dew Democratic Yea
Allen Buansi Democratic Yea
Allison A. Dahle Democratic Nay
Amber M. Baker Democratic Yea
Amos L. Quick, III Democratic Yea
B. Ray Jeffers Democratic Not Voting
Becky Carney Democratic Yea
Beth Helfrich Democratic Yea
Brandon Lofton Democratic Yea
Brian Turner Democratic Yea
Bryan Cohn Democratic Yea
Carolyn G. Logan Democratic Yea
Cecil Brockman Democratic Yea
Cynthia Ball Democratic Nay
Dante Pittman Democratic Yea
Deb Butler Democratic Not Voting
Eric Ager Democratic Yea
Garland E. Pierce Democratic Yea
Gloristine Brown Democratic Yea
James Roberson Democratic Yea
Jordan Lopez Democratic Nay
Julia Greenfield Democratic Yea
Kanika Brown Democratic Not Voting
Laura Budd Democratic Yea
Lindsey Prather Democratic Yea
Marcia Morey Democratic Yea
Maria Cervania Democratic Nay
Mary Belk Democratic Yea
Mike Colvin Democratic Yea
Monika Johnson-Hostler Democratic Nay
Phil Rubin Democratic Yea
Pricey Harrison Democratic Yea
Renée A. Price Democratic Nay
Robert T. Reives, II Democratic Nay
Rodney D. Pierce Democratic Yea
Sarah Crawford Democratic Nay
Shelly Willingham Democratic Yea
Terry M. Brown Jr. Democratic Yea
Tim Longest Democratic Yea
Tracy Clark Democratic Yea
Vernetta Alston Democratic Nay
Ya Liu Democratic Yea
Zack Hawkins Democratic Yea
A. Reece Pyrtle, Jr. Republican Yea
Allen Chesser Republican Yea
Ben T. Moss, Jr. Republican Yea
Bill Ward Republican Yea
Blair Eddins Republican Yea
Brenden H. Jones Republican Yea
Brian Biggs Republican Yea
Brian Echevarria Republican Yea
Celeste C. Cairns Republican Yea
Charles W. Miller Republican Yea
Chris Humphrey Republican Yea
Cody Huneycutt Republican Yea
David Willis Republican Yea
Dean Arp Republican Yea
Dennis Riddell Republican Yea
Destin Hall Republican Yea
Diane Wheatley Republican Yea
Donna McDowell White Republican Yea
Donnie Loftis Republican Yea
Donny Lambeth Republican Yea
Dudley Greene Republican Yea
Edward C. Goodwin Republican Yea
Erin Paré Republican Yea
Frank Iler Republican Yea
Harry Warren Republican Yea
Heather H. Rhyne Republican Yea
Howard Penny, Jr. Republican Yea
Hugh Blackwell Republican Yea
Jarrod Lowery Republican Yea
Jay Adams Republican Yea
Jeff Zenger Republican Yea
Jeffrey C. McNeely Republican Yea
Jennifer Balkcom Republican Yea
Jerry "Alan" Branson Republican Yea
Jimmy Dixon Republican Yea
John A. Torbett Republican Yea
John M. Blust Republican Yea
John R. Bell, IV Republican Yea
John Sauls Republican Yea
Jonathan L. Almond Republican Yea
Joseph Pike Republican Yea
Julia C. Howard Republican Yea
Karl E. Gillespie Republican Yea
Keith Kidwell Republican Yea
Kelly E. Hastings Republican Yea
Kyle Hall Republican Yea
Larry C. Strickland Republican Yea
Larry W. Potts Republican Yea
Mark Brody Republican Yea
Mark Pless Republican Yea
Matthew Winslow Republican Yea
Mike Clampitt Republican Yea
Mike Schietzelt Republican Yea
Mitchell S. Setzer Republican Yea
Neal Jackson Republican Yea
Paul Scott Republican Yea
Phil Shepard Republican Yea
Ray Pickett Republican Yea
Sam Watford Republican Yea
Sarah Stevens Republican Yea
Stephen M. Ross Republican Not Voting
Steve Tyson Republican Yea
Ted Davis, Jr. Republican Yea
Todd Carver Republican Yea
Todd Johnson Republican Yea
Tricia Ann Cotham Republican Yea
William D. Brisson Republican Yea
Wyatt Gable Republican Not Voting
Carla D. Cunningham U Yea
Nasif Majeed U Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 163?
HB 163 is sponsored by Jeff Zenger (Republican), David Willis (Republican), Shelly Willingham (Democratic), Donna McDowell White (Republican), Diane Wheatley (Republican), Bill Ward (Republican), Steve Tyson (Republican), Larry C. Strickland (Republican), Mitchell S. Setzer (Republican), Paul Scott (Republican), Reeder, A. Reece Pyrtle, Jr. (Republican), Joseph Pike (Republican), Ben T. Moss, Jr. (Republican), Charles W. Miller (Republican), Jeffrey C. McNeely (Republican), Donnie Loftis (Republican), Keith Kidwell (Republican), Chris Humphrey (Republican), Julia C. Howard (Republican), Pricey Harrison (Democratic), Allen Chesser (Republican), Todd Carver (Republican), Campbell, William D. Brisson (Republican), Jerry "Alan" Branson (Republican), Brian Biggs (Republican), Jennifer Balkcom (Republican), Jonathan L. Almond (Republican), Eric Ager (Democratic), Jarrod Lowery (Republican), Cody Huneycutt (Republican), Hugh Blackwell (Republican), Heather H. Rhyne (Republican), and Jake Johnson (Republican).
What is the current status of HB 163?
This bill has passed the House. Introduced February 21, 2025. It now moves to the second chamber.
Where can I track HB 163?
Track HB 163 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 163

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 163

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →